Jiafan Bai , Yuhao Liu , Xiangli Chen , Linyu Wang , Jie Shi , Hongyan Liu , Wenzhen Peng , Yuancong Zhao , Jie Weng , Wei Zhi , Jianxin Wang
{"title":"Drug loaded hydrogel nanoparticles with long retention in tumor and multi drug co delivery for melanoma treatment","authors":"Jiafan Bai , Yuhao Liu , Xiangli Chen , Linyu Wang , Jie Shi , Hongyan Liu , Wenzhen Peng , Yuancong Zhao , Jie Weng , Wei Zhi , Jianxin Wang","doi":"10.1016/j.colsurfb.2025.114962","DOIUrl":null,"url":null,"abstract":"<div><div>This study aims to address the issue of immune clearance and inaccurate targeting of drug-loaded nanoparticles during intravenous injection, which may lead to partial drug release into non target tissues or organs, damage to normal tissues and low drug utilization. Herein, multi-drug co-delivery nanoparticles with intratumoral long retention capability were developed for melanoma treatment. This study adopted a dual drug loading strategy of curcumin and dexamethasone and designed a drug-loaded nano-system based on polyglutamic acid and caffeic acid. The results indicate that the introduction of caffeic acid endowed nanoparticles with the property of long-term retention in melanoma sites, while also obtaining a certain inhibitory effect on melanoma growth and good antioxidant properties. To make nanoparticles more stable in water environment, we employed esterification reaction to introduce ester bond to enhance the water resistance of nanoparticles, thus giving them stability in water environment. Two drugs with different hydrophilicity were co-loaded into nanoparticles through grafting and π-π stacking. The experimental results in vitro and in vivo indicate that such strategy and design have achieved long-term retention of nanoparticles at tumor site, and meanwhile allow nanoparticles to effectively inhibit the growth and metastasis of tumor cells, achieving ideal therapeutic effects on melanoma treatment.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"255 ","pages":"Article 114962"},"PeriodicalIF":5.4000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colloids and Surfaces B: Biointerfaces","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0927776525004692","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0
Abstract
This study aims to address the issue of immune clearance and inaccurate targeting of drug-loaded nanoparticles during intravenous injection, which may lead to partial drug release into non target tissues or organs, damage to normal tissues and low drug utilization. Herein, multi-drug co-delivery nanoparticles with intratumoral long retention capability were developed for melanoma treatment. This study adopted a dual drug loading strategy of curcumin and dexamethasone and designed a drug-loaded nano-system based on polyglutamic acid and caffeic acid. The results indicate that the introduction of caffeic acid endowed nanoparticles with the property of long-term retention in melanoma sites, while also obtaining a certain inhibitory effect on melanoma growth and good antioxidant properties. To make nanoparticles more stable in water environment, we employed esterification reaction to introduce ester bond to enhance the water resistance of nanoparticles, thus giving them stability in water environment. Two drugs with different hydrophilicity were co-loaded into nanoparticles through grafting and π-π stacking. The experimental results in vitro and in vivo indicate that such strategy and design have achieved long-term retention of nanoparticles at tumor site, and meanwhile allow nanoparticles to effectively inhibit the growth and metastasis of tumor cells, achieving ideal therapeutic effects on melanoma treatment.
期刊介绍:
Colloids and Surfaces B: Biointerfaces is an international journal devoted to fundamental and applied research on colloid and interfacial phenomena in relation to systems of biological origin, having particular relevance to the medical, pharmaceutical, biotechnological, food and cosmetic fields.
Submissions that: (1) deal solely with biological phenomena and do not describe the physico-chemical or colloid-chemical background and/or mechanism of the phenomena, and (2) deal solely with colloid/interfacial phenomena and do not have appropriate biological content or relevance, are outside the scope of the journal and will not be considered for publication.
The journal publishes regular research papers, reviews, short communications and invited perspective articles, called BioInterface Perspectives. The BioInterface Perspective provide researchers the opportunity to review their own work, as well as provide insight into the work of others that inspired and influenced the author. Regular articles should have a maximum total length of 6,000 words. In addition, a (combined) maximum of 8 normal-sized figures and/or tables is allowed (so for instance 3 tables and 5 figures). For multiple-panel figures each set of two panels equates to one figure. Short communications should not exceed half of the above. It is required to give on the article cover page a short statistical summary of the article listing the total number of words and tables/figures.